Cardiovascular safety profile of a fixed-dose combination of glycopyrrolate and formoterol fumarate delivered via metered dose inhaler using co-suspension delivery technology
2018 ◽
Vol 49
◽
pp. 67-74
◽
2018 ◽
Vol 53
◽
pp. 33-38
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):